Viking Therapeutics Cash Flow Statement
NASDAQ: VKTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
28.51+0.78 (+2.81%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Viking Therapeutics free cash flow
In fiscal 2025, Viking Therapeutics generated -$278.7 million of operating cash flow. That left free cash flow of -$278.7 million.
Summary generated from market data by MetaCap's automated system. Methodology
Viking Therapeutics cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -359.64M | -109.96M | -85.89M | -68.87M | -54.99M | -39.49M | -25.78M | -22.06M | -20.58M | -14.73M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | 40.82M | 29.71M | 16.75M | 8.67M | 6.10M | 5.82M | 3.74M | 2.61M | 1.45M | 1.79M |
| Change in Working Capital | 44.41M | 8.56M | 3.57M | 9.76M | -3.76M | 5.46M | -5.49M | 823.00K | 1.77M | 809.22K |
| Operating Cash Flow | -278.69M | -87.79M | -73.38M | -48.40M | -47.59M | -21.78M | -24.75M | -18.75M | -14.76M | -11.07M |
| Investing Cash Flow | 341.39M | -553.37M | -179.09M | 54.75M | 37.96M | 41.57M | 7.46M | -265.73M | -1.73M | 3.03M |
| Share Repurchases | — | — | — | -6.79M | — | — | — | — | — | -229 |
| Financing Cash Flow | 76.44M | 612.46M | 271.38M | 4.16M | 6.88M | 950.00K | 887.00K | 300.27M | 22.40M | 10.35M |
| Net Change in Cash | 139.14M | -28.69M | 18.91M | 10.52M | -2.75M | 20.74M | -16.40M | 15.79M | 5.91M | 2.31M |
| Free Cash Flow | -278.69M | -87.79M | -73.38M | -48.40M | -47.59M | -21.78M | -24.75M | -18.75M | -14.76M | -11.07M |
This table shows 10 annual periods of Viking Therapeutics's cash flow statement, from FY 2025 back to FY 2016, across 9 line items including net income, stock-based compensation, change in working capital. Values in USD; B = billions, M = millions. Fiscal periods follow VKTX's reporting calendar. What is a cash flow statement?